Preventing the Financing of Illegal Synthetic Drugs Act
Official title: A bill to require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Preventing the Financing of Illegal Synthetic Drugs Act
This bill requires the Government Accountability Office to study illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2227: Preventing the Financing of Illegal Synthetic Drugs Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2227/
"S. 2227: Preventing the Financing of Illegal Synthetic Drugs Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2227/.
S. 2227, 118th Cong. (2026), https://openamerica.io/bill/118-S-2227/.
[S. 2227: Preventing the Financing of Illegal Synthetic Drugs Act](https://openamerica.io/bill/118-S-2227/)